Assyro AI

Orange Book product · Brand (NDA)

EPANED

ENALAPRIL MALEATE

Brand (NDA)NDA 208686TE ABRX AZURITY
View ENALAPRIL MALEATE familyOpen on FDA Orange Book

At a glance

Sep 20, 2016

Approved

Brand (NDA)

Application

AB

TE code

17

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Sep 20, 2016

    9 yr 11 mo ago

  2. Today

  3. Patent 10039745 expires

    Listed drug product patent expiration.

    Mar 25, 2036

    in 9 yr 11 mo

  4. Patent 10154987 expires

    Listed method-of-use patent (U-3) expiration.

    Mar 25, 2036

    in 9 yr 11 mo

  5. Patent 10154987 expires

    Listed method-of-use patent (U-1892) expiration.

    Mar 25, 2036

    in 9 yr 11 mo

  6. Patent 10154987 expires

    Listed method-of-use patent (U-185) expiration.

    Mar 25, 2036

    in 9 yr 11 mo

  7. Patent 10154987 expires

    Listed method-of-use patent (U-71) expiration.

    Mar 25, 2036

    in 9 yr 11 mo

  8. Patent 10154987 expires

    Listed method-of-use patent (U-1723) expiration.

    Mar 25, 2036

    in 9 yr 11 mo

  9. Patent 10772868 expires

    Listed drug product patent expiration.

    Mar 25, 2036

    in 9 yr 11 mo

  10. Patent 10786482 expires

    Listed drug product patent expiration.

    Mar 25, 2036

    in 9 yr 11 mo

  11. Patent 11040023 expires

    Listed drug product patent expiration.

    Mar 25, 2036

    in 9 yr 11 mo

  12. Patent 11141405 expires

    Listed drug product patent expiration.

    Mar 25, 2036

    in 9 yr 11 mo

  13. Patent 11173141 expires

    Listed drug product patent expiration.

    Mar 25, 2036

    in 9 yr 11 mo

  14. Patent 9669008 expires

    Listed drug product patent expiration.

    Mar 25, 2036

    in 9 yr 11 mo

  15. Patent 9808442 expires

    Listed method-of-use patent (U-71) expiration.

    Mar 25, 2036

    in 9 yr 11 mo

  16. Patent 9808442 expires

    Listed method-of-use patent (U-1723) expiration.

    Mar 25, 2036

    in 9 yr 11 mo

  17. Patent 9808442 expires

    Listed method-of-use patent (U-185) expiration.

    Mar 25, 2036

    in 9 yr 11 mo

  18. Patent 9808442 expires

    Listed method-of-use patent (U-1892) expiration.

    Mar 25, 2036

    in 9 yr 11 mo

  19. Patent 9808442 expires

    Listed method-of-use patent (U-3) expiration.

    Mar 25, 2036

    in 9 yr 11 mo

Pharmaceutical detail

Active ingredient

ENALAPRIL MALEATE

Strength

1MG/ML

Dosage form

SOLUTION

Route

ORAL

TE code

AB

Application

NDA 208686

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (17)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10039745Mar 25, 2036in 9 yr 11 mo
Product
10154987Mar 25, 2036in 9 yr 11 mo
U-3
10154987Mar 25, 2036in 9 yr 11 mo
U-1892
10154987Mar 25, 2036in 9 yr 11 mo
U-185
10154987Mar 25, 2036in 9 yr 11 mo
U-71
10154987Mar 25, 2036in 9 yr 11 mo
U-1723
10772868Mar 25, 2036in 9 yr 11 mo
Product
10786482Mar 25, 2036in 9 yr 11 mo
Product
11040023Mar 25, 2036in 9 yr 11 mo
Product
11141405Mar 25, 2036in 9 yr 11 mo
Product
11173141Mar 25, 2036in 9 yr 11 mo
Product
9669008Mar 25, 2036in 9 yr 11 mo
Product
9808442Mar 25, 2036in 9 yr 11 mo
U-71
9808442Mar 25, 2036in 9 yr 11 mo
U-1723
9808442Mar 25, 2036in 9 yr 11 mo
U-185
9808442Mar 25, 2036in 9 yr 11 mo
U-1892
9808442Mar 25, 2036in 9 yr 11 mo
U-3
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo